milrinone has been researched along with landiolol in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Fujii, Y; Hoshi, T; Miyabe, M; Takahashi, S; Toyooka, H; Uemura, A | 1 |
Doi, M; Fukuta, S; Kobayashi, S; Matsuzaki, M; Murakami, W; Nao, T; Okamura, T; Okuda, S; Susa, T; Tanaka, T; Wada, Y; Yamada, J; Yano, M | 1 |
Yasumura, Y | 1 |
Ishii, T; Izawa, K; Kinoshita, M; Masuda, M; Onoda, T; Sato, N; Tanaka, H; Urano, A | 1 |
4 other study(ies) available for milrinone and landiolol
Article | Year |
---|---|
Milrinone attenuates the negative inotropic effects of landiolol in halothane-anesthetized dogs.
Topics: Adrenergic beta-Antagonists; Anesthesia, Inhalation; Anesthetics, Inhalation; Animals; Cardiotonic Agents; Dogs; Halothane; Heart Rate; Milrinone; Morpholines; Myocardial Contraction; Urea | 2003 |
Low-dose β-blocker in combination with milrinone safely improves cardiac function and eliminates pulsus alternans in patients with acute decompensated heart failure.
Topics: Acute Disease; Adrenergic beta-Antagonists; Adult; Aged; Arrhythmias, Cardiac; Cardiotonic Agents; Chi-Square Distribution; Drug Therapy, Combination; Female; Heart Failure; Heart Rate; Hemodynamics; Humans; Japan; Male; Middle Aged; Milrinone; Morpholines; Prospective Studies; Pulmonary Wedge Pressure; Recovery of Function; Stroke Volume; Time Factors; Treatment Outcome; Urea; Ventricular Dysfunction, Left; Ventricular Function, Left | 2012 |
Combination of β-blocker and milrinone for acute heart failure.
Topics: Adrenergic beta-Antagonists; Arrhythmias, Cardiac; Cardiotonic Agents; Female; Heart Failure; Hemodynamics; Humans; Male; Milrinone; Morpholines; Urea; Ventricular Dysfunction, Left; Ventricular Function, Left | 2012 |
[Chemical Stability after Mixing Continuous Infusion Drugs Used to Treat Cardiogenic Shock].
Topics: Dobutamine; Humans; Milrinone; Norepinephrine; Pharmaceutical Preparations; Shock, Cardiogenic | 2022 |